Literature DB >> 15365814

Parkinson's disease: clinical aspects.

Thomas Klockgether1.   

Abstract

Parkinsonism is a clinical syndrome characterized by akinesia, muscular rigidity, and resting tremor. The most frequent cause of parkinsonism is Parkinson's disease (PD). Progressive loss of substantia nigra neurons together with the occurrence of Lewy bodies are considered essential neuropathological features of PD. Recent neuropathological studies suggest that nigral degeneration is only part of a more extended brain degeneration that starts in the medulla oblongata and then spreads to the mesencephalon and cerebral cortex. Correspondingly, the clinical symptoms occurring in PD go far beyond parkinsonism. Depending on the disease stage, autonomic dysfunction, olfactory disturbances, depression, and dementia are frequently encountered in PD. These neuropathological and clinical observations have major implications for future research in PD. In particular, the analysis of the properties that the neuronal cell types involved in PD have in common and that might make them susceptible to degeneration is essential.

Entities:  

Mesh:

Year:  2004        PMID: 15365814     DOI: 10.1007/s00441-004-0975-6

Source DB:  PubMed          Journal:  Cell Tissue Res        ISSN: 0302-766X            Impact factor:   5.249


  32 in total

1.  A soluble α-synuclein construct forms a dynamic tetramer.

Authors:  Wei Wang; Iva Perovic; Johnathan Chittuluru; Alice Kaganovich; Linh T T Nguyen; Jingling Liao; Jared R Auclair; Derrick Johnson; Anuradha Landeru; Alana K Simorellis; Shulin Ju; Mark R Cookson; Francisco J Asturias; Jeffrey N Agar; Brian N Webb; Chulhee Kang; Dagmar Ringe; Gregory A Petsko; Thomas C Pochapsky; Quyen Q Hoang
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-17       Impact factor: 11.205

Review 2.  Rodent models and contemporary molecular techniques: notable feats yet incomplete explanations of Parkinson's disease pathogenesis.

Authors:  Sharawan Yadav; Anubhuti Dixit; Sonal Agrawal; Ashish Singh; Garima Srivastava; Anand Kumar Singh; Pramod Kumar Srivastava; Om Prakash; Mahendra Pratap Singh
Journal:  Mol Neurobiol       Date:  2012-06-27       Impact factor: 5.590

3.  Effects of age, gender, and gonadectomy on neurochemistry and behavior in animal models of Parkinson's disease.

Authors:  Andrea Tamás; Andrea Lubics; István Lengvári; Dóra Reglodi
Journal:  Endocrine       Date:  2006-04       Impact factor: 3.633

4.  Pathway for Parkinson disease.

Authors:  Quyen Q Hoang
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-07       Impact factor: 11.205

5.  Role of secondary mediators in caffeine-mediated neuroprotection in maneb- and paraquat-induced Parkinson's disease phenotype in the mouse.

Authors:  Sharawan Yadav; Satya Prakash Gupta; Garima Srivastava; Pramod Kumar Srivastava; Mahendra Pratap Singh
Journal:  Neurochem Res       Date:  2011-12-27       Impact factor: 3.996

6.  Altered expression of vesicular glutamate transporters VGLUT1 and VGLUT2 in Parkinson disease.

Authors:  Alireza Kashani; Catalina Betancur; Bruno Giros; Etienne Hirsch; Salah El Mestikawy
Journal:  Neurobiol Aging       Date:  2006-03-24       Impact factor: 4.673

7.  Neuroprotective effect of diclofenac on chlorpromazine induced catalepsy in rats.

Authors:  Sadaf Naeem; Rahila Najam; Saira Saeed Khan; Talat Mirza; Bushra Sikandar
Journal:  Metab Brain Dis       Date:  2019-05-04       Impact factor: 3.584

8.  Cognitive impairment in 873 patients with idiopathic Parkinson's disease. Results from the German Study on Epidemiology of Parkinson's Disease with Dementia (GEPAD).

Authors:  Oliver Riedel; Jens Klotsche; Annika Spottke; Günther Deuschl; Hans Förstl; Fritz Henn; Isabella Heuser; Wolfgang Oertel; Heinz Reichmann; Peter Riederer; Claudia Trenkwalder; Richard Dodel; Hans-Ulrich Wittchen
Journal:  J Neurol       Date:  2008-01-22       Impact factor: 4.849

9.  Fas-associated factor 1 and Parkinson's disease.

Authors:  Ranjita Betarbet; Leah R Anderson; Marla Gearing; Tiffany R Hodges; Jason J Fritz; James J Lah; Allan I Levey
Journal:  Neurobiol Dis       Date:  2008-05-29       Impact factor: 5.996

10.  Prodromal non-motor symptoms of Parkinson's disease.

Authors:  Clelia Pellicano; Dario Benincasa; Vincenzo Pisani; Francesca R Buttarelli; Morena Giovannelli; Francesco E Pontieri
Journal:  Neuropsychiatr Dis Treat       Date:  2007-02       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.